from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1470/trxA

LFCtreatmentdescriptionclass of inhibitor

0.101

Amikacinug/mL Amikacintranslation

1.817

Cap5-10ug/mL Capreomycintranslation

0.579

Rox10-50 ug/mL Roxithromycintranslation

-0.286

SM2-5 ug/mL Streptomycintranslation

-0.514

Tet5-10 ug/mL Tetracyclinetranslation

0.061

Rif0.2-5ug/mL Rifampicintranscription

0.553

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.153

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.179

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.705

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.331

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.531

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.458

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.906

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.160

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.519

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.657

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.759

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-2.554

Nigericin50 uM Nigericinrespiration

0.555

TRC10-150 ug/mL Triclosanrespiration

0.973

TRZ10-25 ug/mL Thioridazinerespiration

-0.145

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.471

menadione6-10 ug/mL Menadionerespiration

-0.127

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.262

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.037

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.575

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.638

NRP_1Non-replicating persistence stage 1dosRassociated

-0.702

Amp0.2mg/mL AmpicillincellWall

1.291

Cephalexin20-100 ug/mL CephalexincellWall

0.334

Cerulenin0.32-5 ug/mL CerulenincellWall

0.113

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.426

EMB10-20 ug/mL EthambutolcellWall

0.122

Eta12-40 ug/mL EthionamidecellWall

-0.449

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.408

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.626

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.295

BZA0.12 mg/mL BenzamidearomaticAmides

-0.302

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.810

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.372

H2O24 mM hydrogen peroxideDNAdamaging

0.147

Levo10 ug/mL LevofloxacinDNAdamaging

-0.067

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.032

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.313

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.262

UVUV-irradiationDNAdamaging

0.308

ARP41-4 ug/mL Antitubercular compound ARP4?

0.068

Antimycin12.5-50 ug/mL Antimycin A?

-2.112

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.261

PA_110-50 ug/mL Antitubercular compound PA-1?

0.366

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.560

PA8240.2-2 ug/mL PA-824?

-0.932

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.376

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-4.617

Verapamil50 uM Verapamil?

0.535

mercaptoethanol2 mM 2-Mercaptoethanol?

0.463

methoxatin10-20 ug/mL Methoxatin?